Funding for this research was provided by:
Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen
Seventh Framework Programme (305444 (RD-Connect), 305121 (NeurOmics))
Deutsche Gesellschaft für Muskelkranke
Text and Data Mining valid from 2018-05-02
Received: 27 December 2017
Accepted: 9 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: Not applicable.
: The authors have consent to use the image shown in Fig. InternalRef removed.
: The authors declare that they do not have any competing interests.OP and HL have served as investigators on clinical trials and and a Disease Monitoring Programme for GNE myopathy carried out by Newcastle University and the Newcastle NHS Trust sponsored by Ultragenyx Pharmaceuticals (NCT01784679, NCT02377921, NCT02736188).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.